Jeewon focuses on the formation and representation of private investment funds – including venture capital funds, private equity funds, funds of funds and other private investment vehicles – in the US and internationally.
Amplify Partners Announces Three New Funds Totaling $900 Million
June 18, 2025
Cooley advised Amplify Partners, an early-stage venture capital firm dedicated to technical founders, on the formation of three new funds – Fund 6, Fund 6 Select and Amplify Bio – with a combined $900 million in capital.
Theory Ventures Announces $450 Million Second Fund
November 22, 2024
Cooley advised Theory Ventures, a venture capital firm focused on early-stage software investments across data, artificial intelligence and Web3, on its $450 million second fund.
Longboard Pharmaceuticals Announces $2.6 Billion Sale to Lundbeck
October 14, 2024
Cooley advised Longboard Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, on its $2.6 billion sale to Lundbeck.
Personalis Announces Expanded Collaboration With Tempus AI
August 16, 2024
Cooley advised Personalis, a company transforming the active management of cancer through breakthrough personalized testing, on its expanded commercial relationship with Tempus AI, including an equity investment by Tempus into Personalis.
Summer Fridays Announces Strategic Investment From TSG Consumer Partners
July 25, 2024
Cooley advised Summer Fridays – a clean, premium skincare and hybrid makeup brand – on its strategic growth investment from TSG Consumer Partners, a top private equity firm.
